Fredun Pharmaceuticals Limited
Fredun Pharmaceuticals Limited scores highest on Earnings (66) and lowest on Price (27). Its PosiPenta is 43.73 out of 100, around the middle of similar companies.
On the Penta Grid this week, Fredun Pharmaceuticals Limited is Grid #114 of 168 in the Healthcare sector in India, and Grid #1,583 of 2,356 in India.
Compared with similar companies in the Healthcare sector in India.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Fredun Pharmaceuticals Limited | 43.73 | 27 | 66 | 61 | 36 | 29 |
| KMC Speciality Hospitals (India) Limited | 41.58 | 28 | 24 | 58 | 60 | 38 |
| Hikal Limited | 42.16 | 43 | 48 | 59 | 8 | 53 |
| Dr. Agarwal's Eye Hospital Limited | 55.23 | 43 | 96 | 45 | 46 | 45 |
| Dishman Carbogen Amcis Limited | 33.29 | 53 | 54 | 10 | 16 | 33 |
| Medi Assist Healthcare Services Limited | 43.51 | 76 | 43 | 9 | 57 | 33 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | 50.53 |
| P/B ratio | 8.44 |
EEarnings
| Trailing EPS | ₹27.53 |
| Forward EPS | — |
NNitro
| Price | 1391.00 |
| 52-week high | 1665.00 |
| 52-week low | 1195.20 |
| Fall from 52-week high | 16.5% |
TTorque
| Return on equity (ROE) (calculated) | 16.70% |
| Debt-to-equity | 0.87 |
AAnchor
| Beta (price swings) | 0.86 |
| Market cap | ₹2,376 Cr |
| Promoter holding | 43.62% |
| Dividend yield | 0.05% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Fredun Pharmaceuticals Limited's PosiPenta score?
Fredun Pharmaceuticals Limited's PosiPenta is 43.73 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Fredun Pharmaceuticals Limited stand on the Penta Grid?
On the Penta Grid this week, Fredun Pharmaceuticals Limited is Grid #114 of 168 in the Healthcare sector in India, and Grid #1,583 of 2,356 in India.
Which PosiPenta pillar is strongest for Fredun Pharmaceuticals Limited?
Earnings (growth), with a score of 66 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Fredun Pharmaceuticals Limited?
Price (valuation), with a score of 27 out of 100: weaker than most similar companies.
PositoAI is for research and education only and is not investment advice.